Market Optimism Abounds: Telomir Pharmaceuticals (TELO) Stock Rises Significantly

Telomir Pharmaceuticals, Inc. (NASDAQ: TELO) witnessed a substantial surge in its market performance during Thursday’s trading session, marking a remarkable 28.93% increase, culminating in shares closing at $7.31. This notable upswing in TELO’s stock price closely followed the announcement of its esteemed involvement in a significant forthcoming event. Telomir Pharmaceuticals (TELO) revealed that Dr. Michael […]

The Baxter Report
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.